Introduction {#Sec1}
============

Oxygen therapy is commonly administered in critical care and emergency medicine. Its benefits are well known but potential side-effects may be underestimated. Compliance to recommendations remains dependent on staff workload. We developed FreeO~2~, an innovative device that automatically titrates oxygen flow delivered through nasal cannulas or masks to maintain the patients in the SpO~2~ target set by the clinician^1^.

Objectives {#Sec2}
==========

To compare FreeO~2~ with oxygen manual adjustment, in patient admitted to the emergency department (ED) for acute respiratory failure (ARF).

Methods {#Sec3}
=======

We conducted a multicentre randomized controlled study. Inclusion criteria were: admission to ED for ARF requiring O~2~≥3L/min. Main exclusion criteria were: O~2~≥15 L/min, immediate need for ventilatory support. After inclusion, patients were randomized to either FreeO~2~ or conventional O~2~ manual adjustment during 3 hours. The randomization was web-based and stratified for the type of respiratory failure (hypoxemia/hypercapnia) and for the centre. Primary outcome was the % of time with SpO~2~ within the predefined target (92-96% for hypoxemic patients; 88-92% for hypercapnic patients). Secondary endpoints were: frequency of severe hypoxemia (SpO~2~ \< 85%) and hyperoxia (SpO~2~\> 98%), partial or complete oxygen weaning at the ED, total O~2~ duration, ventilator support use, ICU admissions, ICU and hospital LOS.

Results {#Sec4}
=======

187 patients were randomized (93 FreeO~2~ and 94 Manual). Baseline physiological characteristics were similar in the 2 groups: age = 76 ± 12 yrs., 35% of COPD patients; mean O~2~ flow at inclusion was 5.8 ± 3.1 L/min. No serious adverse events related to the protocol or device was recorded. The percentage of time within the SpO~2~ target was 81 ± 21% in the FreeO~2~ arm and 51 ± 30% in the Manual arm (P \< 0.001). Percentage of time with severe hypoxemia and with hyperoxia were significantly lower with FreeO~2~ (P \< 0.001). The percentage of patients with O~2~ flow reduction of more than 50% during the 3 hours of the study was 39% with FreeO~2~ vs 19% in the Manual arm (P = 0.011). Percentage of O~2~ weaning at the end of the study (3h) was 4.3% in the FreeO~2~ arm vs. 14.1 % in the Manual arm; p \< 0.001. Significantly less patients in the hypercapnic subgroup were transferred in the ICU, overall O~2~ administration and hospital LOS were significantly reduced in the non-adjusted analysis (9.2 ± 6.9 vs 11.1 ± 7.0, P = 0.01).

Conclusions {#Sec5}
===========

The automation of oxygen therapy with FreeO~2~ at the ED improves the oxygenation parameters with more time in the specified SpO~2~ target, less desaturation and less hyperoxia. FreeO~2~ may reduce staff workload and improve the compliance to recommendations for oxygen administration with potential related clinical benefits
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